Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: BIOLOGICAL: therapeutic allogeneic lymphocytes
Sponsor: University of Medicine and Dentistry of New Jersey
Collaborators: National Cancer Institute (NCI)